FBXW7 attenuates tumor drug resistance and enhances the efficacy of immunotherapy

被引：7
|
作者：
Chen, Shimin [1 ,2 ,3 ]
Lin, Jichun [1 ,2 ,3 ]
Zhao, Jiaojiao [1 ,2 ,3 ]
Lin, Qian [1 ]
Liu, Jia [4 ]
Wang, Qiang [5 ]
Mui, Ryan [6 ]
Ma, Leina [1 ,2 ]
机构：
[1] Qingdao Univ, Canc Inst, Dept Oncol, Affiliated Hosp, Qingdao, Peoples R China
[2] Qingdao Canc Inst, Qingdao, Peoples R China
[3] Qingdao Univ, Sch Basic Med, Qingdao, Peoples R China
[4] Qingdao Univ, Sch Pharm, Dept Pharmacol, Qingdao, Peoples R China
[5] Shandong Second Prov Gen Hosp, Oncol Dept, Jinan, Peoples R China
[6] Sparrow Hosp, Dept Gastroenterol, Lansing, MI USA
来源：
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
基金：
中国国家自然科学基金;
关键词：
FBXW7; drug resistance; E3; ligase; cancer; immunotherapy; F-BOX PROTEINS; GASTRIC-CANCER; MESENCHYMAL TRANSITION; PROMOTES PROLIFERATION; CHEMO-RESISTANCE; CYCLIN-E; C-MYC; FBW7; DEGRADATION; EXPRESSION;
D O I：
10.3389/fonc.2023.1147239
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FBXW7 (F-box and WD repeat domain containing 7) is a critical subunit of the Skp1-Cullin1-F-box protein (SCF), acting as an E3 ubiquitin ligase by ubiquitinating targeted protein. Through degradation of its substrates, FBXW7 plays a pivotal role in drug resistance in tumor cells and shows the potential to rescue the sensitivity of cancer cells to drug treatment. This explains why patients with higher FBXW7 levels exhibit higher survival times and more favorable prognosis. Furthermore, FBXW7 has been demonstrated to enhance the efficacy of immunotherapy by targeting the degradation of specific proteins, as compared to the inactivated form of FBXW7. Additionally, other F-box proteins have also shown the ability to conquer drug resistance in certain cancers. Overall, this review aims to explore the function of FBXW7 and its specific effects on drug resistance in cancer cells.
引用
收藏
页数：14
相关论文
共 50 条
  • [41] Loss of Fbxw7 Impairs Development of and Induces Heterogeneous Tumor Formation in the Mouse Mammary Gland
    Onoyama, Ichiro
    Nakayama, Shogo
    Shimizu, Hideyuki
    Nakayama, Keiichi, I
    CANCER RESEARCH, 2020, 80 (24) : 5515 - 5530
  • [42] Pseudophosphatase STYX promotes tumor growth and metastasis by inhibiting FBXW7 function in colorectal cancer
    He, Diao
    Ma, Zida
    Fang, Chao
    Ding, Jingjing
    Yang, Wenming
    Chen, Peng
    Huang, Libin
    Wang, Cun
    Yu, Yongyang
    Yang, Lie
    Li, Yuan
    Zhou, Zongguang
    CANCER LETTERS, 2019, 454 : 53 - 65
  • [43] Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation
    Fujii, Yo
    Yada, Masayoshi
    Nishiyama, Masaaki
    Kamura, Takumi
    Takahashi, Hidehisa
    Tsunematsu, Ryosuke
    Susaki, Etsuo
    Nakagawa, Tadashi
    Matsumoto, Akinobu
    Nakayama, Keiichi I.
    CANCER SCIENCE, 2006, 97 (08): : 729 - 736
  • [44] FBXW7α attenuates inflammatory signalling by downregulating C/EBPδ and its target gene Tlr4
    Balamurugan, Kuppusamy
    Sharan, Shikha
    Klarmann, Kimberly D.
    Zhang, Youhong
    Coppola, Vincenzo
    Summers, Glenn H.
    Roger, Thierry
    Morrison, Deborah K.
    Keller, Jonathan R.
    Sterneck, Esta
    NATURE COMMUNICATIONS, 2013, 4
  • [45] FBXW7α attenuates inflammatory signalling by downregulating C/EBPδ and its target gene Tlr4
    Kuppusamy Balamurugan
    Shikha Sharan
    Kimberly D. Klarmann
    Youhong Zhang
    Vincenzo Coppola
    Glenn H. Summers
    Thierry Roger
    Deborah K. Morrison
    Jonathan R. Keller
    Esta Sterneck
    Nature Communications, 4
  • [46] FBXW7β loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth
    Wei, Wenxia
    Qin, Baifu
    Wen, Weijie
    Zhang, Boyu
    Luo, Haidan
    Wang, Yuzhi
    Xu, Hui
    Xie, Xiaoshan
    Liu, Sicheng
    Jiang, Xin
    Wang, Mengan
    Tang, Qin
    Zhang, Jiayu
    Yang, Runxiang
    Fan, Zongmin
    Lyu, Haiwen
    Lin, Junzhong
    Li, Kai
    Lee, Mong-Hong
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [47] The FBXW7 tumor suppressor inhibits breast cancer proliferation and promotes apoptosis by targeting MTDH for degradation
    Chen, X.
    Li, X. Y.
    Long, M.
    Wang, X.
    Gao, Z. W.
    Cui, Y.
    Ren, J.
    Zhang, Z.
    Liu, C.
    Dong, K.
    Zhang, H.
    NEOPLASMA, 2018, 65 (02) : 201 - 209
  • [48] MicroRNA-367a promotes tumor growth and stemness potential by targeting FBXW7 in breast cancer
    Xiao, G.
    Zhang, J.
    Sun, X.
    Qin, S.
    Zhang, B.
    Liu, D.
    Liu, J.
    Ren, H.
    CANCER RESEARCH, 2017, 77
  • [49] FBXW7β loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth
    Wenxia Wei
    Baifu Qin
    Weijie Wen
    Boyu Zhang
    Haidan Luo
    Yuzhi Wang
    Hui Xu
    Xiaoshan Xie
    Sicheng Liu
    Xin Jiang
    Mengan Wang
    Qin Tang
    Jiayu Zhang
    Runxiang Yang
    Zongmin Fan
    Haiwen Lyu
    Junzhong Lin
    Kai Li
    Mong-Hong Lee
    Signal Transduction and Targeted Therapy, 8
  • [50] Expression of FBXW7 in endometrial cancer negatively correlates with mTORC1 activity and tumor progression
    Liping, W.
    Yuping, W.
    Xuefei, W.
    Huihui, Z.
    Zhenguo, C.
    Mei, Z.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2018, 39 (05) : 803 - 807
12345